Lincoln National Corp’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,714
| Closed | -$2.05M | – | 231 |
|
|
2024
Q1 | $2.05M | Sell |
25,714
-199
| -0.8% | -$15.2K | 0.03% | 319 |
|
|
2023
Q4 | $2.05M | Sell |
25,913
-2,189
| -8% | -$156K | 0.04% | 286 |
|
|
2023
Q3 | $1.96M | Buy |
28,102
+950
| +3% | +$67.3K | 0.04% | 249 |
|
|
2023
Q2 | $1.88M | Sell |
27,152
-306
| -1% | -$21.8K | 0.04% | 269 |
|
|
2023
Q1 | $2.04M | Sell |
27,458
-587
| -2% | -$49.2K | 0.04% | 229 |
|
|
2022
Q4 | $2.61M | Buy |
28,045
+1,117
| +4% | +$108K | 0.06% | 187 |
|
|
2022
Q3 | $2.57M | Buy |
26,928
+908
| +3% | +$89.9K | 0.06% | 171 |
|
|
2022
Q2 | $2.41M | Sell |
26,020
-1,561
| -6% | -$152K | 0.06% | 187 |
|
|
2022
Q1 | $2.79M | Buy |
27,581
+328
| +1% | +$34.5K | 0.06% | 175 |
|
|
2021
Q4 | $2.81M | Buy |
27,253
+4,204
| +18% | +$388K | 0.06% | 174 |
|
|
2021
Q3 | $1.96M | Buy |
23,049
+71
| +0.3% | +$5.95K | 0.04% | 208 |
|
|
2021
Q2 | $1.92M | Buy |
22,978
+1,282
| +6% | +$105K | 0.04% | 208 |
|
|
2021
Q1 | $1.63M | Buy |
21,696
+401
| +2% | +$29.2K | 0.04% | 220 |
|
|
2020
Q4 | $1.45M | Buy |
21,295
+1,943
| +10% | +$126K | 0.04% | 221 |
|
|
2020
Q3 | $1.13M | Buy |
19,352
+4,206
| +28% | +$262K | 0.03% | 236 |
|
|
2020
Q2 | $984K | Buy |
15,146
+1,494
| +11% | +$94.1K | 0.03% | 252 |
|
|
2020
Q1 | $810K | Sell |
13,652
-1,374
| -9% | -$91.7K | 0.03% | 245 |
|
|
2019
Q4 | $1.12M | Buy |
15,026
+2,045
| +16% | +$144K | 0.04% | 240 |
|
|
2019
Q3 | $819K | Buy |
12,981
+4,420
| +52% | +$262K | 0.03% | 258 |
|
|
2019
Q2 | $467K | Sell |
8,561
-5,020
| -37% | -$270K | 0.02% | 335 |
|
|
2019
Q1 | $733K | Buy |
13,581
+3,302
| +32% | +$204K | 0.03% | 246 |
|
|
2018
Q4 | $673K | Buy |
10,279
+4,844
| +89% | +$362K | 0.03% | 223 |
|
|
2018
Q3 | $428K | Sell |
5,435
-220
| -4% | -$15.7K | 0.01% | 295 |
|
|
2018
Q2 | $364K | Sell |
5,655
-551
| -9% | -$36.3K | 0.01% | 320 |
|
|
2018
Q1 | $386K | Sell |
6,206
-6,091
| -50% | -$437K | 0.01% | 311 |
|
|
2017
Q4 | $892K | Buy |
12,297
+6,264
| +104% | +$455K | 0.03% | 251 |
|
|
2017
Q3 | $490K | Sell |
6,033
-1,904
| -24% | -$151K | 0.02% | 217 |
|
|
2017
Q2 | $639K | Buy |
7,937
+885
| +13% | +$69.9K | 0.03% | 164 |
|
|
2017
Q1 | $553K | Buy |
7,052
+1,531
| +28% | +$122K | 0.03% | 175 |
|
|
2016
Q4 | $435K | Sell |
5,521
-3,390
| -38% | -$274K | 0.02% | 188 |
|
|
2016
Q3 | $793K | Buy |
8,911
+1,093
| +14% | +$103K | 0.04% | 134 |
|
|
2016
Q2 | $748K | Buy |
7,818
+1,743
| +29% | +$174K | 0.04% | 133 |
|
|
2016
Q1 | $630K | Buy |
6,075
+2,428
| +67% | +$236K | 0.04% | 139 |
|
|
2015
Q4 | $341K | Buy |
3,647
+113
| +3% | +$11.1K | 0.03% | 145 |
|
|
2015
Q3 | $350K | Buy |
3,534
+80
| +2% | +$8.41K | 0.03% | 130 |
|
|
2015
Q2 | $384K | Sell |
3,454
-543
| -14% | -$55.5K | 0.03% | 128 |
|
|
2015
Q1 | $412K | Buy |
3,997
+896
| +29% | +$90.7K | 0.03% | 120 |
|
|
2014
Q4 | $298K | Buy |
3,101
+176
| +6% | +$15.5K | 0.03% | 127 |
|
|
2014
Q3 | $233K | Buy |
2,925
+108
| +4% | +$8.51K | 0.02% | 132 |
|
|
2014
Q2 | $212K | Buy |
+2,817
| New | +$213K | 0.02% | 132 |
|
Other funds holding CVS
Lincoln National Corp's CVS Position: Q2 2024 in Review
Lincoln National Corp sold out of CVS Health (CVS) in Q2 2024, closing a stake of 25,714 shares — an estimated $2.05M sold.
Lincoln National Corp first reported a position in CVS in Q2 2014 and held it in 40 quarters. The position peaked at $2.81M in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Lincoln National Corp reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Lincoln National Corp sold 25,714 CVS Health shares in Q2 2024, an estimated $2.05M.
- Lincoln National Corp first reported a position in CVS Health in Q2 2014 and held it in 40 quarters.
- Lincoln National Corp's CVS Health position peaked at $2.81M in Q4 2021.
- 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.